Publication | Open Access

Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

UrologyBaseline Neutrophil–lymphocyte RatioMedicineCancer ManagementCancer TreatmentBaseline Steroid UseProstatic DiseaseOncologyRadiation OncologySecond-line Chemotherapy